Jump Financial’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-33,374
Closed -$1.2M 2080
2026
Q1
$1.2M Buy
+33,374
New +$864K 0.02% 850
2025
Q4
Sell
-47,500
Closed -$867K 1977
2025
Q3
$867K Buy
+47,500
New +$781K 0.01% 1081
2024
Q1
Sell
-14,000
Closed -$250K 1936
2023
Q4
$250K Buy
+14,000
New +$227K 0.01% 1435
2023
Q3
Sell
-13,400
Closed -$213K 1892
2023
Q2
$213K Buy
+13,400
New +$221K 0.01% 1494
2023
Q1
Sell
-36,400
Closed -$614K 1648
2022
Q4
$614K Buy
36,400
+22,400
+160% +$361K 0.03% 685
2022
Q3
$179K Sell
14,000
-309
-2% -$4.43K 0.01% 1371
2022
Q2
$149K Sell
14,309
-8,921
-38% -$119K 0.01% 1368
2022
Q1
$316K Sell
23,230
-6,770
-23% -$99.6K 0.01% 1043
2021
Q4
$396K Buy
30,000
+20,000
+200% +$252K 0.02% 762
2021
Q3
$79K Sell
10,000
-4,600
-32% -$31.7K 0.01% 997
2021
Q2
$100K Sell
14,600
-8,900
-38% -$54.9K 0.01% 977
2021
Q1
$143K Buy
+23,500
New +$98.1K 0.01% 801

Other funds holding CLMT

Jump Financial's CLMT Position: Q2 2026 in Review

Jump Financial sold out of Calumet Specialty Products (CLMT) in Q2 2026, closing a stake of 33,374 shares — an estimated $1.2M sold.

Jump Financial first reported a position in CLMT in Q1 2021 and held it in 12 quarters. The position peaked at $1.2M in Q1 2026. 189 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Jump Financial reported no remaining Calumet Specialty Products position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 33,374 Calumet Specialty Products shares in Q2 2026, an estimated $1.2M.
  • Jump Financial first reported a position in Calumet Specialty Products in Q1 2021 and held it in 12 quarters.
  • Jump Financial's Calumet Specialty Products position peaked at $1.2M in Q1 2026.
  • 189 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.